Medicare Watch articles are featured in a weekly newsletter that helps readers stay up-to-date on Medicare policy and advocacy developments, and learn about changes in Medicare benefits and rules.
Last week, we covered new KFF research on Medicare Advantage (MA) television advertisements that aired during the Fall of 2022,
In advance of the upcoming Medicare Fall Open Enrollment period, beginning October 15, the Biden-Harris administration announced that Medicare Advantage
Two new KFF research reports capture the prolific—and often problematic—nature of Medicare Advantage (MA) television advertisements during Medicare’s fall open
This week, the Centers for Medicare & Medicaid Services (CMS) finalized a long-awaited rule that will make it easier for
A new survey from the Commonwealth Fund examines beneficiary experiences with marketing outreach from private Medicare Advantage (MA), Medigap, and
This week, Medicare Rights submitted comments on three proposed rules. One would improve access to needed services. A second would
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will
This article was written in coordination with the Center for Medicare Advocacy and the Legal Action Center. As our country
In advance of this week’s one-year anniversary of the Inflation Reduction Act (IRA), the Biden-Harris administration released a set of
This week marked the one-year anniversary of the signing of the Inflation Reduction Act (IRA), landmark legislation that allows Medicare
Last week, we covered new KFF research on Medicare Advantage (MA) television advertisements that aired during the Fall of 2022,
In advance of the upcoming Medicare Fall Open Enrollment period, beginning October 15, the Biden-Harris administration announced that Medicare Advantage
Two new KFF research reports capture the prolific—and often problematic—nature of Medicare Advantage (MA) television advertisements during Medicare’s fall open
This week, the Centers for Medicare & Medicaid Services (CMS) finalized a long-awaited rule that will make it easier for
A new survey from the Commonwealth Fund examines beneficiary experiences with marketing outreach from private Medicare Advantage (MA), Medigap, and
This week, Medicare Rights submitted comments on three proposed rules. One would improve access to needed services. A second would
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will
This article was written in coordination with the Center for Medicare Advocacy and the Legal Action Center. As our country
In advance of this week’s one-year anniversary of the Inflation Reduction Act (IRA), the Biden-Harris administration released a set of
This week marked the one-year anniversary of the signing of the Inflation Reduction Act (IRA), landmark legislation that allows Medicare
